Development and validation of HPLC method for simultaneous determination of Leflunomide and folic acid in the nanoparticulate system by reversed-phase HPLC-Reference-Cited by-同舟云学术

Development and validation of HPLC method for simultaneous determination of Leflunomide and folic acid in the nanoparticulate system by reversed-phase HPLC

Published:2023-07-25 Issue:8 Volume:49 Page:497-507
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Siddiqui Bazla¹,Ahmed Haroon¹,Haq Ihsan-ul-¹,Rehman Asim.ur.¹,Ahmed Naveed¹

Affiliation:

1. Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan

Funder

Ph.D. Indigenous Scholarship

Higher Education Commission (HEC) of Pakistan

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2023.2239346

Reference38 articles.

1. Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases

2. Imunossupressor leflunomide anodic behaviour at a boron-doped diamond electrode

3. Effects of leflunomide on human cartilage

4. Leflunomide for the Treatment of Rheumatoid Arthritis and Autoimmunity

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Performance Liquid Chromatography (HPLC) Method Validation for Identifying and Quantifying Rebamipide in Ethosomes;Cureus;2024-03-12

2. Folate decorated chitosan-chondroitin sulfate nanoparticles loaded hydrogel for targeting macrophages against rheumatoid arthritis;Carbohydrate Polymers;2024-03

3. Targeted delivery and apoptosis induction of CDK-4/6 inhibitor loaded folic acid decorated lipid-polymer hybrid nanoparticles in breast cancer cells;International Journal of Pharmaceutics;2024-02

4. Analytical Method Development, Validation and In-Vitro Determination of Fusidic Acid in SLN Formulation by Reversed Phase HPLC;2024